NCT06574620 2026-01-16
ACCELERATE
British Columbia Cancer Agency
Phase NA Recruiting
Clinical Trials
4 trialsNCT06635980 2025-12-12
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
Mayo Clinic
Phase 2 Recruiting
NCT04323202 2025-10-24
Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N
Case Comprehensive Cancer Center
Phase 1 Completed
NCT04239040 2025-03-19
GVAX Plus Checkpoint Blockade in Neuroblastoma
Dana-Farber Cancer Institute
Phase 1 Terminated